The Medicines Australia chief concedes the conversation gets uncomfortable when it turns to pricing, but argues the alternative is worse. “Sometimes it is an uncomfortable conversation to talk about fair pricing, but it is not as uncomfortable as delays and medicine departures are for patients fearing for their health.” …
Medicines Australia chief says next negotiation is about getting comfortable with being uncomfortable
July 3, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
BMS therapy secures Australian approval for psoriatic arthritis
September 3, 2026 - -
The live lesson from the UK on who holds the levers and how they use them
September 3, 2026 - -
Gilead returns to Medicines Australia as industry prepares to make the case for innovation
September 3, 2026 - - Latest News -
Combined monitoring of key indicators as the future of diabetes care
September 3, 2026 - -
ENA Respiratory secures funding to test antiviral nasal spray in people with asthma
September 2, 2026 - -
OncoSil pursues a reimbursement pathway as it prepares for US rollout
September 2, 2026 - - Australian Biotech -
Vitrafy takes its cryopreservation technology into the US cell therapy market
September 2, 2026 - - Australian Biotech